US FDA Advisory Committee meetings held to discuss isotretinoin, safety issues and a new accutane formulation.
Maddin
S
S
Division of Dermatology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
D000152:Acne Vulgaris / Q000188:drug therapy*; D002626:Chemistry, Pharmaceutical; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D015474:Isotretinoin